Pune, India -- (SBWIRE) -- 09/26/2018 -- Sleeping Bruxism Treatment Market – Summary

The global sleeping bruxism treatment market is expected to touch USD 638.22 million valuation by 2023, expanding at a modest CAGR of 6.7% during the forecast period (2018-2023), reports Market Research Future (MRFR). Sleeping bruxism is a disorder in which people grind or clench their teeth during sleep. This incident is quite natural. However, if the rate goes higher, it can damage the teeth or affect the jaw muscles.
According to a study published by Sleep Research Society (SRS), generally 5-8% people suffer from this disorder resulting in tooth wear and headaches which inadvertently distresses their lifestyle. This can give rise to preventive measures such as anti-depressants, mouth guard, muscle relaxants, and others and provide a favorable condition for the market.

Request for Sample Report at https://www.marketresearchfuture.com/sample_request/5422

Report Overview:

This report allows the user to gain a deeper understanding of the current events and trends in the market for sleeping bruxism treatment. By correlating the historical data with key market dynamics, our analysts were able to make highly accurate projections in the report. MRFR's report includes a thorough segmental analysis of the sleeping bruxism treatment market segmented on the basis of type, diagnosis, treatment type, cause, patient type, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will also come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.

Segment Overview:

By type, the sleeping bruxism treatment market has been segmented into primary and secondary bruxism. The secondary bruxism segment accounted for 72.7% share in 2017 owing to smoking or consumption of alcohol. It is expected to touch a valuation of USD 469.48 million by 2023.

By diagnosis, the market is segmented into clinical examination, electromyographic methods, polysomnography, and x-rays. By treatment type, the market is segmented into dental approaches and medication. The dental approaches segment will be the largest by 2023 owing to the treatment offered to children for preventing teeth and jaw damage. By cause, the market is segmented into malocclusion, sleep paralysis, obstructive sleep apnea, and gastroesophageal reflux disease (GERD). The obstructive sleep apnea segment is likely to reach USD 233.20 million by 2023, growing at a 7% CAGR over the forecast period.

By patient type, the market is segmented into pediatric and adults. The pediatric segment is expected to continue to dominate during the forecast period owing to sleeping bruxism more commonly occurring in children. The segment can touch USD 440.28 million by 2023.

Major market end-users include hospitals, dental clinics, and others. Hospitals and dental clinics can collectively account for a large market share owing to availability of various treatment methods. The hospital segment can generate market demand at a 6.3% CAGR over the forecast period. 

 Check Discount Here at https://www.marketresearchfuture.com/check-discount/5422

The segments and sub-segments covered in the report are analyzed under four major regions –Americas, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA), with respective country-level market sizing. For the scope of research, the standard definition of the medical method "sleeping bruxism treatment" is included in the report. The report discusses and interprets the current and future opportunities of the industry by delivering an unbiased growth assessment.

Key Players:

Pfizer

Carestream Dental

Ipsen Biopharmaceuticals

PLANMECA OY

Henry Schein

Patterson Dental Supply and more.

Regional Segmentation:

Geographically the market covers the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas dominated the market in 2017 by holding 39.1% of the market share. This is due to the rising cases of stress and anxiety related diseases among the populace. According to the American Sleep Association, 10% of the adults and 15% of the children are affected by the disease. Almost 8.3 million of the U.S. population are suffering from the disease as reported by the World Socialist Website in 2017. The market in the region, with an astounding 6.9% CAGR can reach USD 252.27 million by 2023.

Europe is the second largest market where as per the European Orthodontic Society in 2014-2015 sleeping bruxism was prevalent in 14 to 20% of children, 8 to 12% of teenagers and 3% of the adult population. Obstructive sleep apnea syndrome is also a significant factor in the growth of this market as according to the reports of the European Lung Foundation, 3-7% male and 2-5% female suffer from the disease.

APAC is expected to open up possibilities owing to its significant investment in healthcare, economic growth, large population base, and adoption of advanced healthcare technology. As per the reports of State of the World's Children 2016, UNICEF, South Asia has 627 million children population, almost 36% of the total population and the number is on the rise giving the market a favorable condition. Also, bruxism and dental care related awareness are spreading rapidly in countries such as India, China, Japan and South Korea which can boost the market.

Ask Any Question at https://www.marketresearchfuture.com/enquiry/5422

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com